Loading organizations...
Loading organizations...
Biotechnology company developing therapeutics for mitochondrial dysfunction
MitoRx Therapeutics has raised $12.3M across 2 funding rounds.
MitoRx Therapeutics has raised $12.3M in total across 2 funding rounds.
MitoRx Therapeutics has raised $12.3M in total across 2 funding rounds.
MitoRx Therapeutics's investors include Justin Cahill, Fink Family Office, Longevity Tech Fund, Oxford Technology Management, Science Angel Syndicate, Oliver Sexton, Wren Capital.
MitoRx Therapeutics has raised $12.3M across 2 funding rounds. Most recently, it raised $7.3M Pre-Series A in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2025 | $7.3M Pre-Series A | Justin Cahill | |
| Dec 18, 2023 | $5.1M Seed | Fink Family Office, Longevity Tech Fund, Oxford Technology Management, Science Angel Syndicate, Oliver Sexton, Wren Capital |